title: [Surgical site infections in vaginal prolapse surgery].
abstract: BACKGROUND
  Vaginal prolapse surgery is at high risk of surgical site infections (SSI) because it's a "clean-contaminated surgery" and it's frequently associated with implantation of meshes.
  
  
  OBJECTIVE
  To evaluate the rate of SSI and associated risk factors in vaginal prolapse surgery with mesh support.
  
  
  METHODS
  In a retrospective unicenter study, two groups of patients were operated by vaginal route for a pelvic floor reconstructive surgery with mesh support. Colporraphy was made by classic surgical sutures non-coated (Monosyn(®) 3/0, B-Braun) in the first group, and surgical sutures coated with triclosan in the second group. We collected risk factors of SSIs using the procedure of the CCLIN and analyzed the occurrence of SSIs with a statistical comparative univariate analysis.
  
  
  RESULTS
  Study included 78 patients in the first group and 72 in the second group. SSIs total rate was 2.6 % (4 of 150), as part of 3 in the group with surgical sutures non-coated and one in the group with surgical sutures coated with triclosan (P=0.62).
  
  
  CONCLUSIONS
  In our study, SSIs rate in vaginal prolapse surgery was twice higher than classic gynecologic surgery. As the interest of using a surgical suture coated with triclosan to reduce SSI has not been demonstrated statistically, we can't recommend it.
authors.affiliation: Service de gynécologie-obstétrique, CHU Carémeau, place du Pr-Debré, 30900 Nîmes, France.
authors.forename: A
authors.initials: A
authors.lastname: Hedde-Parison
authors.forename: A
authors.initials: A
authors.lastname: Minchella
authors.forename: S
authors.initials: S
authors.lastname: Bastide
authors.forename: A
authors.initials: A
authors.lastname: Cornille
authors.forename: B
authors.initials: B
authors.lastname: Fatton
authors.forename: R
authors.initials: R
authors.lastname: de Tayrac
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage; D019072:Antibiotic Prophylaxis; D002983:Clinical Competence; D020099:Coated Materials, Biocompatible; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007902:Length of Stay / Q000706:statistics & numerical data; D008875:Middle Aged; D061646:Operative Time; D012189:Retrospective Studies; D012307:Risk Factors; D013526:Surgical Mesh; D013530:Surgical Wound Infection / Q000209:etiology* / Q000517:prevention & control*; D013537:Sutures; D014260:Triclosan / Q000008:administration & dosage; D014552:Urinary Tract Infections / Q000150:complications; D014596:Uterine Prolapse / Q000601:surgery*
chemical_list: D000891:Anti-Infective Agents, Local; D020099:Coated Materials, Biocompatible; D014260:Triclosan
keywords: Chirurgie vaginale; Colporraphie; Colporraphy; Infection; Mesh; Prolapse; Prolapsus; Prothèse; Triclosan; Vaginal surgery